Yüklüyor......
Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome
Haemolytic uraemic syndrome (HUS) remains a leading cause of paediatric acute kidney injury (AKI). Haemolytic uraemic syndrome is characterised by the triad of microangiopathic haemolytic anaemia, thrombocytopenia and AKI. In ~ 90% of cases, HUS is a consequence of infection with Shiga toxin-produci...
Kaydedildi:
| Yayımlandı: | Pediatr Nephrol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer Berlin Heidelberg
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6660499/ https://ncbi.nlm.nih.gov/pubmed/30058046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-018-4025-0 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|